Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy.
Vento
S
S
Garofano
T
T
Renzini
C
C
Casali
F
F
Ferraro
T
T
Concia
E
E
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000821:virology; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D004359:Drug Therapy, Combination; D006678:HIV / Q000254:growth & development / Q000302:isolation & purification; D015658:HIV Infections / Q000188:drug therapy*; D016174:Hepacivirus / Q000254:growth & development* / Q000302:isolation & purification / Q000502:physiology; D006526:Hepatitis C / Q000473:pathology* / Q000821:virology; D006801:Humans; D007249:Inflammation; D008099:Liver / Q000276:immunology / Q000473:pathology*; D018655:Lymphocyte Count; D012367:RNA, Viral / Q000032:analysis; D019562:Viral Load; D014779:Virus Replication / Q000187:drug effects
D019380:Anti-HIV Agents; D012367:RNA, Viral